Report Published: "Kazakhstan Pharmaceuticals & Healthcare Report Q3 2014"
Kazakhstan's expanding pharmaceutical industry will continue to be primarily driven by the demand for gene ric drugs, which currently make up over a third of total sales of the market, as the government makes more progress in its efforts to widen the country's currently limited coverage. The Kazakh government's continued commitment to increasing expenditure on healthcare along with rising local wages will drive growth in the healthcare sector.
View full press release